Literature DB >> 15716634

Thrombocytopenia predicts progressive hemorrhage after head trauma.

Martin Engström1, Bertil Romner, Wilhelm Schalén, Peter Reinstrup.   

Abstract

Patients with traumatic brain injury (TBI) often show progression of hemorrhagic injuries (PHI) after admission to the hospital. This progression is correlated with poor outcome. In this study, we have investigated if thrombocytopenia was a risk factor for PHI. The study was performed on patients admitted to the hospital with severe TBI during year 2000. In total, 50 patients were admitted with severe TBI. Twenty-seven out of these had complete platelet counts at admission and 24 hours thereafter and were included for further study. We found thrombocytopenia at admission to be a risk factor for PHI (p=0.008). We also found that the platelet count decreased more significantly during the first 24 h after injury in patients with PHI compared to patients without PHI (p=0.009). A trend towards longer periods of mechanical ventilation in patients with PHI compared to patients without PHI was identified. These findings support a causal relationship between thrombocytopenia and PHI. The findings provide a rationale for future studies of hemostatic agents in the treatment of TBI in order to minimise complications caused by PHI.

Entities:  

Mesh:

Year:  2005        PMID: 15716634     DOI: 10.1089/neu.2005.22.291

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  24 in total

1.  [Progredient intracranial bleeding after traumatic brain injury. When is a control CCT necessary?].

Authors:  T Vogel; B Ockert; M Krötz; U Linsenmaier; C Kirchhoff; K J Pfeifer; W Mutschler; T Mussack
Journal:  Unfallchirurg       Date:  2008-11       Impact factor: 1.000

2.  D-dimer as a predictor of progressive hemorrhagic injury in patients with traumatic brain injury: analysis of 194 cases.

Authors:  Heng-Li Tian; Hao Chen; Bing-Shan Wu; He-Li Cao; Tao Xu; Jin Hu; Gan Wang; Wen-Wei Gao; Zai-Kai Lin; Shi-Wen Chen
Journal:  Neurosurg Rev       Date:  2010-03-27       Impact factor: 3.042

Review 3.  Hemorrhagic progression of a contusion after traumatic brain injury: a review.

Authors:  David Kurland; Caron Hong; Bizhan Aarabi; Volodymyr Gerzanich; J Marc Simard
Journal:  J Neurotrauma       Date:  2011-12-05       Impact factor: 5.269

4.  A risk score based on admission characteristics to predict progressive hemorrhagic injury from traumatic brain injury in children.

Authors:  Guo-Wen Hu; Hai-Li Lang; Hua Guo; Lei Wu; Pei Zhang; Wei Kuang; Xin-Gen Zhu
Journal:  Eur J Pediatr       Date:  2017-03-25       Impact factor: 3.183

5.  Derivation of a Predictive Score for Hemorrhagic Progression of Cerebral Contusions in Moderate and Severe Traumatic Brain Injury.

Authors:  Randall Z Allison; Kazuma Nakagawa; Michael Hayashi; Daniel J Donovan; Matthew A Koenig
Journal:  Neurocrit Care       Date:  2017-02       Impact factor: 3.210

6.  Subarachnoid hemorrhage prevalence and its association with short-term outcome in pediatric severe traumatic brain injury.

Authors:  Elana Hochstadter; Tanya Charyk Stewart; Ibrahim M Alharfi; Adrianna Ranger; Douglas D Fraser
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

7.  Impact of Coagulation Profile on Outcome of Head Injury.

Authors:  Gulzar Gupta; Chetan Wadhwa; Rajveer Garg; Ranbir S Dhaiya; Rakesh K Kaushal
Journal:  J Clin Diagn Res       Date:  2016-01-01

Review 8.  Coagulopathy associated with traumatic brain injury.

Authors:  Monisha A Kumar
Journal:  Curr Neurol Neurosci Rep       Date:  2013-11       Impact factor: 5.081

9.  Traumatic brain injury associated coagulopathy.

Authors:  Airton Leonardo de Oliveira Manoel; Antonio Capone Neto; Precilla V Veigas; Sandro Rizoli
Journal:  Neurocrit Care       Date:  2015-02       Impact factor: 3.210

10.  Transfusion in Traumatic Brain Injury.

Authors:  G Duemani Reddy; Shankar Gopinath; Claudia S Robertson
Journal:  Curr Treat Options Neurol       Date:  2015-11       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.